With the Dec. 7 deadline for Medicare’s annual enrollment period fast approaching, Smart Insurance Company is working with Walgreens to offer in–store consultations with licensed SmartD Rx plan agents, available at select Walgreens to speak with Medicare beneficiaries who are either enrolling in a new Part D prescription drug plan or evaluating their current coverage options.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59273-smart-insurance-company-walgreens-smartd-rx-open-enrollment-ends-dec-7
Buckling precious cargo into a late-model vehicle has gotten a bit easier in the past year, the Institute’s LATCH ease-of-use ratings show.
IIHS launched its ratings of child seat installation hardware in vehicles in June 2015. Out of 102 vehicles rated at that time, the majority were poor or marginal. Today, a total of 170 current models have been evaluated, and most are good or acceptable. Three models — the Audi Q7, Lexus RX and Toyota Prius — earn the top rating of good+, a distinction that no vehicle achieved last year.
A properly installed, age-appropriate child restraint can protect a child much better in a crash than a safety belt alone. LATCH, which stands for Lower Anchors and Tethers for Children, is intended to make it easier for caregivers to install child restraints properly. Child restraints installed with LATCH are more likely to be put in correctly than restraints installed using the vehicle safety belt, IIHS research has shown.
Even with LATCH, installation errors are common. The Institute’s ratings are based on key ease-of-use criteria that have been shown to minimize mistakes.
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
